Literature DB >> 19442564

CYP1A2*1C, CYP2E1*5B, and GSTM1 polymorphisms are predictors of risk and poor outcome in head and neck squamous cell carcinoma patients.

Eloisa Helena Ribeiro Olivieri1, Sabrina Daniela da Silva, Fernando Fernandes Mendonça, Yuri Nagamine Urata, Daniel Onofre Vidal, Marcilia de Araujo Medrado Faria, Inês Nobuko Nishimoto, Claudia Aparecida Rainho, Luiz Paulo Kowalski, Silvia Regina Rogatto.   

Abstract

Head and neck squamous cell carcinoma (HNSCC) is associated with environmental factors, especially tobacco and alcohol consumption. Most of the carcinogens present in tobacco smoke are converted into DNA-reactive metabolites by cytochrome P450 (CYPs) enzymes and detoxification of these substances is performed by glutathione S-transferases (GSTs). It has been suggested that genetic alterations, such as polymorphisms, play an important role in tumorigenesis and HNSCC progression. The aim of this study was to investigate CYP1A1, CYP1A2, CYP2E1, GSTM1, and GSTT1 polymorphisms as risk factors in HNSCC and their association with clinicopathologic data. The patients comprised 153 individuals with HNSCC (cases) and 145 with no current or previous diagnosis of cancer (controls). Genotyping of the single nucleotide polymorphisms (SNPs) of the CYP1A1, CYP1A2, and CYP2E1 genes was performed by PCR-RFLP and the GSTM1 and GSTT1 copy number polymorphisms (CNPs) were analyzed by PCR-multiplex. As expected, a significant difference was detected for tobacco and alcohol consumption between cases and controls (P<0.001). It was observed that the CYP1A2*1D (OR=16.24) variant and GSTM1 null alleles (OR=0.02) confer increased risk of HNSCC development (P<0.001). In addition, head and neck cancer alcohol consumers were more frequently associated with the CYP2E1*5B variant allele than control alcohol users (P<0.0001, OR=190.6). The CYP1A2*1C polymorphism was associated with tumor recurrence (log-rank test, P=0.0161). The CYP2E1*5B and GSTM1 null alleles were significantly associated with advanced clinical stages (T3+T4; P=0.022 and P=0.028, respectively). Overall, the findings suggested that the genetic polymorphisms studied are predictors of risk and are also associated with tumor recurrence, since they are important for determining the parameters associated with tumor progression and poor outcomes in HNSCC.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19442564     DOI: 10.1016/j.oraloncology.2009.03.004

Source DB:  PubMed          Journal:  Oral Oncol        ISSN: 1368-8375            Impact factor:   5.337


  28 in total

1.  Meta-analyses of the effect of cytochrome P450 2E1 gene polymorphism on the risk of head and neck cancer.

Authors:  Dong Lu; Xiaodan Yu; Yukai Du
Journal:  Mol Biol Rep       Date:  2010-11-13       Impact factor: 2.316

2.  Tobacco carcinogen-metabolizing genes CYP1A1, GSTM1, and GSTT1 polymorphisms and their interaction with tobacco exposure influence the risk of head and neck cancer in Northeast Indian population.

Authors:  Javed Hussain Choudhury; Seram Anil Singh; Sharbadeb Kundu; Biswadeep Choudhury; Fazlur R Talukdar; Shilpee Srivasta; Ruhina S Laskar; Bishal Dhar; Raima Das; Shaheen Laskar; Manish Kumar; Wetetsho Kapfo; Rosy Mondal; Sankar Kumar Ghosh
Journal:  Tumour Biol       Date:  2015-02-28

3.  MTHFD1 G1958A, BHMT G742A, TC2 C776G and TC2 A67G polymorphisms and head and neck squamous cell carcinoma risk.

Authors:  Lidia Maria Rebolho Batista da Silva; Ana Lívia Silva Galbiatti; Mariangela Torreglosa Ruiz; Luiz Sérgio Raposo; José Victor Maniglia; Erika Cristina Pavarino; Eny Maria Goloni-Bertollo
Journal:  Mol Biol Rep       Date:  2011-06-01       Impact factor: 2.316

4.  CYP1A1, GSTM1 and GSTT1 polymorphisms, tobacco and alcohol status and risk of head and neck squamous cell carcinoma.

Authors:  Gustavo Jacob Lourenço; Erika Furquim Soledade Neves Silva; José Augusto Rinck-Junior; Carlos Takahiro Chone; Carmen Silvia Passos Lima
Journal:  Tumour Biol       Date:  2011-08-26

5.  Joint effects of alcohol consumption and polymorphisms in alcohol and oxidative stress metabolism genes on risk of head and neck cancer.

Authors:  Anne M Hakenewerth; Robert C Millikan; Ivan Rusyn; Amy H Herring; Kari E North; Jill S Barnholtz-Sloan; William F Funkhouser; Mark C Weissler; Andrew F Olshan
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2011-09-22       Impact factor: 4.254

6.  Association of CYP1A1 and CYP2D6 gene polymorphisms with head and neck cancer in Tunisian patients.

Authors:  Rim Khlifi; Amine Chakroun; Amel Hamza-Chaffai; Ahmed Rebai
Journal:  Mol Biol Rep       Date:  2014-01-22       Impact factor: 2.316

7.  Inter-ethnic differences in genetic polymorphisms of xenobiotic-metabolizing enzymes (CYP1A1, CYP2D6, NAT1 and NAT2) in healthy populations: correlation with the functional in silico prediction.

Authors:  Rim Khlifi; Ghada Ben Salah; Amine Chakroun; Amel Hamza-Chaffai; Ahmed Rebai
Journal:  Mol Biol Rep       Date:  2014-06-17       Impact factor: 2.316

8.  CYP1A1 MspI polymorphism and the risk of oral squamous cell carcinoma: Evidence from a meta-analysis.

Authors:  Shang Xie; Chongdai Luo; Xiaofeng Shan; Shushan Zhao; Jing He; Zhigang Cai
Journal:  Mol Clin Oncol       Date:  2016-02-05

Review 9.  The effect of CYP1A1 and CYP1A2 polymorphisms on gastric cancer risk among different ethnicities: a systematic review and meta-analysis.

Authors:  Huiping Xue; Yan Lu; Zeyun Xue; Bing Lin; Jinxian Chen; Feng Tang; Gang Huang
Journal:  Tumour Biol       Date:  2014-01-19

10.  Polymorphisms in NAT2 and GSTP1 are associated with survival in oral and oropharyngeal cancer.

Authors:  Jesse D Troy; Joel L Weissfeld; Brenda Diergaarde; Ada O Youk; Shama C Buch; Marjorie Romkes; Jennifer R Grandis
Journal:  Cancer Epidemiol       Date:  2013-03-21       Impact factor: 2.984

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.